ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279

ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279 on “Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents”. Our team contributes to the CRC with a project on hyperpolarized nanodiamond as contrast agents for cancer research. Funded initially for a period of 4 years the CRC may be extended for a duration of up to 12 years.

News

Felix Ahnefeld got his first paper published

Julen Pedernales did it again, Best Post Prize at the UniKORN Poster Session 2021

Martin Plenio is listed as highly cited researcher for the fourth time in a row.

Our work on Quantum Physics and Biology featured Local and National Radio

Ludovico Lami wins a Humboldt Fellowship to continue his work in our group for another 2 years

Most Recent Papers

Enhancing Gravitational Interaction between Quantum Systems by a Massive Mediator, Phys. Rev. Lett. 128, 110401 (2022)

Optimizing quantum codes with an application to the loss channel with partial erasure information, Quantum 6, 667 (2022)

On the Significance of Interferometric Revivals for the Fundamental Description of Gravity, Universe, 8, 58 (2022)

Design Principles for Long-Range Energy Transfer at Room Temperature, Phys. Rev. X 11, 041003

Contact

Ulm University
Institute of Theoretical Physics
Albert-Einstein-Allee 11
D - 89069 Ulm
Germany

Tel: ++49 / 731 / 50 - 22911
Fax: ++49 / 731 / 50 - 22924

Office: Building M26, room 4117

Click here if you are interested in applying to the group